The Prothrombin Complex Concentrate Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Prothrombin Complex Concentrate Market?
The market size of the prothrombin complex concentrate has seen significant growth in recent years. The market will expand from $1.29 billion in 2024 to $1.39 billion in 2025, displaying a compound annual growth rate (CAGR) of 7.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Prothrombin Complex Concentrate Industry?
The Prothrombin Complex Concentrate market is projected to grow to a size of $1.86 billion by 2029, with a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Prothrombin Complex Concentrate Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Prothrombin Complex Concentrate Market?
The key drivers in the Prothrombin Complex Concentrate market are:
• Rising demand for rapid coagulation therapies
• An increase in the prevalence of hemophilia and liver diseases
• Expansion in the adoption within emergency medicine
• Increased use in applications within cardiac surgeries
Global Market Segmentation: Identifying Major Prothrombin Complex Concentrate Industry Segments
The prothrombin complex concentrate market covered in this report is segmented –
1) By Product: 3-Factor Prothrombin Complex Concentrates, 4-Factor Prothrombin Complex Concentrates, Other Products
2) By Indication: Haemorrhagic Episodes In Factor IX Deficiency (Haemophilia B), Trauma, Life-Threatening Coagulopathy With Acute Bleeding, Warfarin-Associated Acute, Life-Threatening Bleeding, Non-Warfarin Anticoagulant Reversal With Acute Bleeding
3) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular
4) By End-Use: Hospital And Ambulatory Surgical Centers, Specialty Clinics, Other End Users
Pre-order the 2025 Prothrombin Complex Concentrate Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Prothrombin Complex Concentrate Market?
The key trends in the Prothrombin Complex Concentrate market are:
• The trend of applying AI-driven diagnostics in the prothrombin complex concentrate market is emerging.
• There are ongoing advancements in recombinant coagulation factors which are shaping the market's future.
• The rise in next-generation recombinant PCCs is becoming a significant trend in the market.
• The use of customized dosing algorithms and advancements in blood plasma products are upcoming trends.
Who Are the Top Competitors & Leading Players in the Prothrombin Complex Concentrate Market?
Major companies in the Prothrombin Complex Concentrate market are:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Takeda Pharmaceutical Company Limited
• Novo Nordisk A/S
• CSL Behring GmbH
• Intas Pharmaceuticals Ltd
• Baxter International Inc
• Grifols S.A.
• Octapharma AG
• Kedrion S.p.A
• Haemonetics Corporation
• Green Cross Corporation
• Shanghai RAAS Blood Products Co. Ltd
• Emergent BioSolutions
• LFB Group
• Hualan Biological Engineering Chongqing Co. Ltd.
• Sanquin Blood Supply Foundation
• Bio Products Laboratory Ltd (BPL)
• Prothya Biosolutions B.V.
• China Biologic Products Holdings Inc.
Regional Dominance: Which Area Leads the Global Prothrombin Complex Concentrate Market?
North America was the largest region in the prothrombin complex concentrate market in 2024
